“…Tyrosine hydroxylase immunoreactivity (N'Guyen Legros, 1988) and dopamine concentrations (Harmois, 1990) are also lower in retina of parkinsonians as compared with control subjects. Abnormalities of pattern-VEP and ERG have also been demonstrated in parkinsonians (Bodis-Wollner et al, 1987;Ellis et al, 1987;Nightingale et al, 1986;Stanzione et al, 1989 VEP abnormalities depend on the spatial and temporal frequencies of the visual stimulus (Bodis-Wollner et al, 1986) and are reversed by levodopa treatment (BodisWollner, 1990;Bodis-Wollner et al, 1986). Moreover, thioridazine, a neuroleptic, alters ERG in normal subjects (Filip & Balik, 1978), and chlorpromazine, another dopaminergic blocker, induces alterations of VEP and ERG which are dependent on the spatial frequency of stimulation (Bartel et al, 1990).…”